NSEESOP/ESOS/ESPS19 Jun 2026 · 19 Jun 2026, 07:01 pm

ESOP/ESOS/ESPS

Emcure Pharmaceuticals Limited · EMCURE

✦ AI Summary

Emcure Pharmaceuticals Limited announced the allotment of 20,600 equity shares on June 19, 2026. These shares, each with a face value of Rs. 10, were issued pursuant to the exercise of Employee Stock Options (ESOPs) under the company's 2013 scheme. The Nomination and Remuneration Committee approved this allotment. This action serves to incentivize employees, leading to a minor dilution in the existing shareholding base.

✦ Ask a Question

Ask anything about this announcement — AI will answer based on the filing content.

0/500

Full Announcement

Emcure Pharmaceuticals Limited has informed the Exchange regarding Allotment of 20600 Shares.

Attachments (1)

📄

EMCURE_19062026190130_EPLIntimationAllotmentofEquitySharessd.pdf

pdf

Download →
View document text
Emcure Ref: EPL/CS/SE/0051/2026 Date: June 19, 2026 National Stock Exchange of India Limited BSE Limited Exchange Plaza, C-1, Block G, P J Towers, Bandra Kurla Complex, Bandra (East), Dalal Street, Mumbai – 400 051 Mumbai- 400 001 Script Symbol: EMCURE Scrip Code/Symbol: 544210/ EMCURE Dear Sir/Madam, Subject: Intimation under Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 - Allotment of Equity Shares pursuant to exercise of ESOPs under the Emcure - Employee Stock Option Scheme 2013. Pursuant to Regulation 30 read with Schedule III to the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 (“SEBI Listing Regulations”), we hereby inform that the Nomination and Remuneration Committee of the Board of Directors of the Company, vide its Resolution by Circulation (No. 02 of 2026-27) passed on June 19, 2026, has approved allotment of 20,600 (Twenty Thousand Six Hundred) Equity Shares of Rs. 10/- (Rupees Ten only) each of the Company to the eligible employees, pursuant to Emcure - Employee Stock Option Scheme 2013 (“Emcure ESOS 2013”), upon exercise of 20,600 vested options. Further, consequent to the aforesaid allotment, the issued and paid-up share capital of the Company stands increased as under: From To 18,96,59,547 Equity Shares of Rs. 10/- each 18,96,80,147 Equity Shares of Rs. 10/- each aggregating to Rs.1,89,65,95,470/- aggregating to Rs. 1,89,68,01,470/- The aforesaid Equity Shares shall rank pari passu in all aspects with the existing Equity Shares of the Company. You are requested to take the above information on your records. Thanking you, For Emcure Pharmaceuticals Limited Amruta Yangalwar Company Secretary and Compliance Officer Membership No.: A25687 Emcure Pharmaceuticals Limited Registered Office: Plot No. P-1 & P-2, IT-BT Park, Phase-II, M.I.D.C., Hinjawadi, Pune - 411057, Maharashtra, India Phone Nos.: +91 20 – 35070033/ 35070000 Fax No.: +91 20 3507 0060 E-mail: corporate@emcure.com Website: www.emcure.com CIN: L24231PN1981PLC024251